Theranos
A defunct blood testing company founded by Elizabeth Holmes. It claimed to have developed technology capable of performing hundreds of tests from a single finger-prick drop of blood, which was later exposed as fraud.
Timeline (last 90 days)
Theranos claimed that its "Edison" device could complete hundreds of items ranging from routine biochemistry to complex immunoassays using tiny samples from fingerstick blood.
The core tension in the Holmes case lies in the gap between the ideal narrative and commercial reality: a company that claimed to complete hundreds of tests with a small amount of blood once received the dual endorsement of capital and the media.
Theranos's technological promises proved unfounded and became the factual basis for subsequent investigative reporting, regulatory intervention and criminal trials.
Theranos's testing devices produced erroneous blood results; this is not an abstract business failure but a concrete health risk.
In the Theranos case, Holmes's defense team tried to place her behavior within the cultural tradition of "fake it till you make it," but prosecutors pointed out that when the company knew the technology could not deliver yet still provided erroneous test results to patients, it had already crossed the legal line into fraud.
After Theranos's collapse, the industry did not establish a new regulatory framework, nor did investment institutions engage in systematic reflection.
Theranos's board included former secretaries of state and retired generals, the media was happy to report the "female Steve Jobs" narrative, and investors actively loosened their due diligence.
The U.S. CMS revoked Theranos's clinical laboratory certification, and the company dissolved in 2018.
Theranos never published independently validated clinical data in a peer-reviewed journal, nor did it open its devices to outside experts for inspection.
A 2015 investigative report by The Wall Street Journal revealed that Theranos could actually perform only a few tests, and the accuracy of the results was questionable.
38 more timeline events
All Facts (20)
Nathan Fielder produced a documentary about Theranos founder Elizabeth Holmes.
60%UnverifiedTheranos was once valued at as high as $9 billion.
60%UnverifiedThe core tension in the Holmes case lies in the gap between the ideal narrative and commercial reality: a company that claimed to complete hundreds of tests with a small amount of blood once received the dual endorsement of capital and the media.
50%UnverifiedTheranos claimed that its "Edison" device could complete hundreds of items ranging from routine biochemistry to complex immunoassays using tiny samples from fingerstick blood.
50%UnverifiedTheranos's technological promises proved unfounded and became the factual basis for subsequent investigative reporting, regulatory intervention and criminal trials.
50%UnverifiedTheranos's internal suppression of skeptics was an accelerator of its collapse.
50%UnverifiedAfter Theranos's collapse, the industry did not establish a new regulatory framework, nor did investment institutions engage in systematic reflection.
50%UnverifiedTheranos never published independently validated clinical data in a peer-reviewed journal, nor did it open its devices to outside experts for inspection.
50%UnverifiedTheranos's board included former secretaries of state and retired generals, the media was happy to report the "female Steve Jobs" narrative, and investors actively loosened their due diligence.
50%UnverifiedTheranos's testing devices produced erroneous blood results; this is not an abstract business failure but a concrete health risk.
50%UnverifiedThe checklist for identifying the next Theranos includes: whether the core technology can be independently verified, whether narrative density far exceeds product density, whether the board is composed of domain experts, and whether "undiscussable" internal forbidden zones exist.
50%UnverifiedThe Edison device could in reality reliably perform only a handful of tests, and the company used third-party traditional instruments such as Siemens for the rest of the testing while concealing this fact from investors and partners.
50%UnverifiedTheranos's board was stacked with former secretaries of state, former defense secretaries, and other political figures, yet had almost no members with a clinical laboratory science background.
50%UnverifiedElizabeth Holmes is the founder of Theranos, a company that developed a prototype blood testing device called "Edison".
50%UnverifiedElizabeth Holmes was convicted over the Theranos blood-testing fraud, and in 2022 was sentenced to more than 11 years for four counts of fraud.
50%UnverifiedTheranos was once valued at as much as 9 billion US dollars, and Elizabeth Holmes appeared on the cover of Forbes and was compared to 'the next Steve Jobs'.
50%UnverifiedIn 2003, 19-year-old Elizabeth Holmes dropped out of Stanford to found Theranos, claiming to have developed the 'Edison' device that could complete hundreds of tests with just a finger-prick drop of blood.
50%UnverifiedThe Theranos case became a landmark scandal of Silicon Valley's 'fake it till you make it' culture.
50%UnverifiedIn 2015, a Wall Street Journal investigative report revealed that Theranos's technology had never truly been viable, and that test results mostly relied on third-party devices or even fabricated data.
50%UnverifiedTheranos ultimately collapsed due to technology fraud, and Holmes was convicted and imprisoned.
50%